IMB's latest news, explainers and more
Risk of depression and heart disease linked in women
Get the latest research to your inbox
- In 2017, IMB researchers used life itself to change the world, through discoveries in inflammation, genomics, pain, cardiovascular biology, superbugs, solar biotechnology, cancer, agriculture and more.
Fraser Group Team
Group Leader
Researchers
Honorary Professor David McGiffin
Honorary ProfessorInstitute for Molecular BioscienceResearcher profile is public:0Supervisor:Dr Jacky Suen
Senior Research Fellow & Affiliate Senior Research Fellow of Institute for Molecular BioscienceInstitute for Molecular BioscienceResearcher profile is public:1Supervisor:Researcher biography:Critical Care Medicine focuses on supporting patients, often with one or multiple organ failures. Based at the largest Australian cardiac hospital, our research investigates better ways to support patients with heart and/or lung failure. We explore technological, pharmacological and engineering advances that could help our patients to live longer and better. Our group is world-renowned for clinically relevant large animal models, including heart failure, respiratory failure (ARDS), heart transplantation, sepsis, cardiogenic shock, and more. All our studies use hospital-grade equipment and follow the same clinical guideline to maximise translation. We actively take on honours, MPhil and PhD students from multi-disciplinary backgrounds (science, engineering, medicine, allied health), with a successful track record in supporting our students to secure their own grants and funding. Students are expected to contribute to other studies of the group. For more information about the group, please visit ccrg.org.au, and email if you are interested to join us.
Ms Margaret Passmore
Lab ManagerInstitute for Molecular BioscienceResearcher profile is public:0Supervisor:Dr Molly-rose McInerney
Research OfficerInstitute for Molecular BioscienceResearcher profile is public:1Supervisor:Researcher biography:Dr. Molly-rose A. McInerney.
Post-doctoral Research Fellow at the Critical Care Research Group, The Prince Charles Hospital, Institute of Molecular Bioscience, The University of Queensland. Main research focus is heart transplantation, cardiac critical care, molecular biology and mitochondria.
Dr Nchafatso Obonyo
Postdoctoral Research FellowInstitute for Molecular BioscienceResearcher profile is public:1Supervisor:Researcher biography:Dr Nchafatso G. Obonyo (BSc Hons, MB.ChB, DTM&H, MD/PhD, FCRcert)
Post-doctoral Research Fellow at the Critical Care Research Group-The Prince Charles Hospital, Institute of Molecular Bioscience-The University of Queensland. Main research focus is cardiac critical care and sepsis research.
Visiting Fellow in the Academic Division, Medical Engineering Research Facility, Queenlsand University of Technology. Fellow of the Initiative to Develop African Research Leaders (IDeAL) at the KEMRI-Wellcome Trust Research Programme, Kenya; Global Health Fellow, Wellcome Trust Centre for Global Health Research at Imperial College London,UK.
Recipient of the 2023 Africa Top-40 Under-40 Science Award and the 2023 African Professional in Australia of the Year Award.
Dr Gabriella Abbate
Honorary Research Fellow & Senior Research AssistantInstitute for Molecular BioscienceResearcher profile is public:0Supervisor:Dr Angelo Milani
Honorary FellowInstitute for Molecular BioscienceResearcher profile is public:0Supervisor:Miss Rachana Panduru
Senior Research AssistantInstitute for Molecular BioscienceResearcher profile is public:0Supervisor:Students
Dr Hideaki Nonaka
Adjunct FellowInstitute for Molecular BioscienceResearcher profile is public:0Supervisor:Smythe Group
Group Leader
Associate Professor Mark Smythe
Principal Research Fellow - GLInstitute for Molecular BioscienceResearcher profile is public:1Supervisor:Body:Highlights
Associate Professor Mark Smythe is a medicinal chemist. His expertise lies in transforming interesting molecules into high-value medicines.
His methodology for translating academic discoveries into commercially viable companies has achieved great success. He founded biotech company Protagonist Therapeutics in 2001, which is now a publicly listed company with several compounds in human clinical trials and several others sold to pharmaceutical partners. He and his team worked for 15 years to develop an approach to replace injectable drugs with pills. They took high potency, highly selective peptides that are traditionally broken down quickly by the body, and made them stronger. So, diseases that used to require ‘big-molecule’ injections we can now treat with a ‘constrained peptide’ pill. This has several advantages to the patients and addresses unmet medical needs of various diseases
Associate Professor Smythe has always had a focus on applied research, making things. He studied a Bachelor of Science with Honours in Townsville. He wanted a PhD that was applied, so he took at position at Biota with a focus on Influenza. After working in the US, he accepted a position at the then 3D Centre in Queensland, now the Institute for Molecular Bioscience (IMB). At IMB he uses his expertise to translate discoveries into new drug candidates.
Connect
Researchers
Students
Miss Chynna-Loren Sheremeta
PhD student & Research OfficerInstitute for Molecular BioscienceResearcher profile is public:0Supervisor:- Strap on your running shoes and help us raise funds for cardiovascular research
- PhD student & Casual Research AssistantInstitute for Molecular Bioscience
- Higher degree by research (PhD) studentInstitute for Molecular Bioscience
Pages
Strawberry DNA extraction activity
Extract and view DNA from a strawberry using common household ingredients.
Get started
The Edge: Genetics
People have known for thousands of years that parents pass traits to their children, but it is only relatively recently that our technology has caught up to our curiosity, enabling us to delve into the mystery of how this inheritance occurs, and the implications for predicting, preventing and treating disease.
Subscribe to our newsletter
Get the latest research straight to your inbox.
Stay up-to-date as we answer questions about hot topics, and share the latest news at IMB, Australia’s #1 research institute.
General enquiries
+61 7 3346 2222
imb@imb.uq.edu.au
Media enquiries
IMB fully supports UQ's Reconciliation Action Plan and is implementing actions within our institute.
Support us
Donate to research
100% of donations go to the cause